The constantly advancing various emergency or elective endoscopy procedures are being used for the timely diagnosis, and minimally-traumatic treatment of various chronic ailments like cancer, arthritis, joint injuries, inflammatory bowel diseases (IBD), chronic pancreatitis, obesity, Barrett鈥檚 esophagus, and others.
As estimated by IQ4I analysis, the endoscopy devices global market is expected to reach $39,475.6 million by 2028 growing at a high single-digit CAGR from 2021 to 2028 due to the persistently escalating prevalence, and incidence of chronic diseases across the globe, and the need for early diagnostic, and therapeutic interventions, increasing inclination of patients towards the minimally invasive therapeutic procedures, gradual transition of endoscopy devices market towards single-use endoscopes, the emergence of technologically advanced endoscopy products, the trend of acquisitions, and collaborations in the endoscopy device industry, and the increasing awareness, and adoption of the highly beneficial endoscopic procedures across the emerging nations.
The endoscopy devices global market is categorized into various market segments based on the product, application, end-users, and geography. Based on the type of endoscopy products, the market is segmented into endoscopes, endoscopic instruments, and endoscopic accessories. Among these, the Endoscopic Instruments segment held the largest share in 2021 and is expected to grow at a mid single-digit CAGR from 2021 to 2028 due to the increasing popularity of image-guided endoscopic surveillance, diagnostic, and therapeutic procedures to reduce morbidity, and mortality associated with the highly prevalent chronic diseases across the globe, and the necessity of the various endoscopy instruments to ensure the efficiency, safety, and completeness of an endoscopy procedure.
The global endoscopy devices market based on applications has been classified into Arthroscopy, Pulmonary endoscopy, Laparoscopy, ENT endoscopy, Gastrointestinal endoscopy, Gynecology or obstetrics endoscopy, Neuroendoscopy, Urological endoscopy, and other Endoscopic applications consisting of cardiopulmonary endoscopy, dental endoscopy, ophthalmology endoscopy, and breast endoscopy. Among these, the Gastrointestinal endoscopy segment occupied the largest market share in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the persistently increasing prevalence of chronic diseases of the digestive tract, and the potential of gastrointestinal endoscopy to provide accurate diagnostic, and therapeutic solutions, increasing popularity of endoscopic surveillance as a preventive strategy for gastrointestinal cancer-associated morbidity, and mortality, and the ever-expanding diagnostic, and therapeutic application spectrum of gastrointestinal endoscopy procedures. The laparoscopy segment is the fastest emerging segment growing at a double digit CAGR from 2021 to 2028 due to the steadily escalating prevalence of chronic diseases of the digestive system, female reproductive system, and urinary tract system, and the potential of laparoscopy to provide accurate diagnostic, and therapeutic solutions, and the increasing research, and development activities leading to the emergence of numerous technologically advanced, patient-friendly, cosmetically advantageous laparoscopic procedures.
Based on the end-users, the endoscopy devices global market has been segmented into Hospitals, Endoscopy Ambulatory surgery centers (EASCs), Endoscopy Diagnostic Centers, and others consisting of Academic or Research Institutes, and Office based Endoscopy (OBE) suites. Among the various end-users, the Hospitals segment is the largest, and fastest emerging end-user and is expected to grow at a high single digit CAGR during the forecasted period due to the increased utilization of advanced endoscopy products in these clinical settings, the presence of a large number of sophisticated hospitals in the developed nations, and the constantly increasing number of hospitals with advanced infrastructural facilities in the developing nations.
The endoscopy devices global market is divided into four major geographies namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (ROW). Among these, North America occupied the largest share in the 2021 endoscopy devices global market, and is expected to grow at a mid single digit CAGR during the forecasted period. Persistently elevating chronic disease patient burden in the region, and elevating demand for the early diagnosis, and treatment of these diseases, escalating geriatric population burdened with numerous kinds of chronic diseases in the region, the increasing inclination, and adoption of technologically advanced diagnostic procedures, and minimally invasive therapeutic procedures by the patients of the region, availability of well-developed healthcare infrastructural facilities in the region, presence of several major endoscopy device companies in the region, and their increasing R&D investments in the region for the development of innovative, efficient, and safer endoscopy products, and a conducive regulatory, and reimbursement scenario in the region promoting the adoption of single-use endoscopes in the region are some of the factors that are propelling the endoscopy devices market growth in the region.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
鈥� North America
o U.S.
o Rest of North America
鈥� Europe
o Germany
o France
o U.K.
o Rest of Europe
鈥� Asia-Pacific
o China
o Japan
o India
o Rest of APAC
鈥� Rest of the World (ROW)
o Brazil
o Rest of LATAM
o The Middle East and Others
2 INTRODUCTION 44
2.1 KEY TAKEAWAYS 44
2.2 SCOPE OF THE REPORT 45
2.3 REPORT DESCRIPTION 45
2.4 MARKETS COVERED 52
2.5 STAKEHOLDERS 56
2.6 RESEARCH METHODOLOGY 56
2.6.1 MARKET SIZE ESTIMATION 58
2.6.2 MARKET BREAKDOWN, AND DATA TRIANGULATION 61
2.6.3 SECONDARY SOURCES 62
2.6.4 PRIMARY SOURCES 62
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 63
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 64
2.6.7 ASSUMPTIONS 64
3 MARKET ANALYSIS 66
3.1 INTRODUCTION 66
3.2 MARKET SEGMENTATION 67
3.3 FACTORS INFLUENCING MARKET 71
3.3.1 DRIVERS, AND OPPORTUNITIES 72
3.3.1.1 Persistently escalating incidence, and prevalence of chronic
diseases and the need for early diagnosis, and treatment 72
3.3.1.2 Increasing inclination towards minimally invasive therapeutic
procedures 74
3.3.1.3 The gradual endoscopy market conversion from reusable
to single-use endoscopes 75
3.3.1.4 The emergence of technologically advanced endoscopy products 78
3.3.1.5 Persistently elevating geriatric population with chronic diseases 81
3.3.1.6 Acquisitions and collaborations to open an array of opportunities
for the market to flourish 82
3.3.1.7 Market expansion opportunities in emerging nations 83
3.3.2 RESTRAINTS, AND THREATS 85
3.3.2.1 High cost of the endoscopy devices, and procedures 85
3.3.2.2 Lack of skilled, and trained professionals 86
3.3.2.3 Increasing concerns about the adverse effects associated with
endoscopic procedures 88
3.3.2.4 Stringent regulatory bodies guiding the endoscopy device
manufacturers 89
3.3.2.5 The threat of non-invasive diagnostic, and therapeutic technologies 91
3.3.2.6 Unfavorable reimbursement scenario for the endoscopy procedures 92
3.4 REGULATORY AFFAIRS 93
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 94
3.4.1.1 ISO 9001: 2015 Quality Management System 94
3.4.1.2 ISO 13485 Medical Devices 94
3.4.1.3 ISO 10993 Biological Evaluation Of Medical Devices 95
3.4.2 THE U.S. 95
3.4.3 CANADA 97
3.4.4 EUROPE 98
3.4.5 JAPAN 99
3.4.6 CHINA 100
3.4.7 INDIA 102
3.5 REIMBURSEMENT SCENARIO 105
3.5.1 REIMBURSEMENT TABLE 109
3.6 TECHNOLOGICAL ADVANCEMENTS 133
3.6.1 THERAPEUTIC CAPSULE ENDOSCOPES WITH ACTIVE LOCOMOTION 133
3.6.2 MOLECULAR ENDOSCOPIC IMAGING (MEI) 134
3.6.3 VARIABLE STIFFNESS ENDOSCOPES, AND SHAPE LOCKING DEVICES OR OVERTUBES 135
3.6.4 MINIATURIZED ENDOSCOPES 135
3.6.5 3D ENDOSCOPES 135
3.6.6 NOTES, AND LESS 136
3.6.7 ADVANCED DIAGNOSTIC IMAGING TECHNIQUES 136
3.7 CLINICAL TRIALS 136
3.8 ENDOSCOPES - FDA, AND CE REGULATORY APPROVAL ANALYSIS 138
3.9 PATENT ANALYSIS 146
3.10 SINGLE-USE ENDOSCOPES MARKET 148
3.11 AUTOMATED ENDOSCOPE REPROCESSORS (AER) MARKET 156
3.12 REFURBISHED ENDOSCOPY DEVICES MARKET 159
3.13 PORTER'S FIVE FORCE ANALYSIS 162
3.13.1 THREAT OF NEW ENTRANTS 163
3.13.2 THREAT OF SUBSTITUTES 166
3.13.3 BARGAINING POWER OF SUPPLIERS 168
3.13.4 BARGAINING POWER OF BUYERS 169
3.13.5 COMPETITIVE RIVALRY 170
3.14 SUPPLY CHAIN ANALYSIS 172
3.15 AVERAGE SELLING PRICE (ASP) OF SELECT ENDOSCOPY DEVICES 182
3.16 IMPACT OF COVID-19 ON ENDOSCOPY DEVICES INDUSTRY 187
3.17 MARKET SHARE ANALYSIS 189
3.17.1 ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 189
3.17.2 ARTHROSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 194
3.17.3 PULMONARY ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 197
3.17.4 LAPARPOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 201
3.17.5 UROLOGICAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 204
3.17.6 ENT ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 207
3.17.7 GASTROINTESTINAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 210
3.17.8 GYNECOLOGY ENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 214
3.17.9 NEUROENDOSCOPY DEVICES GLOBAL MARKET SHARE
BY KEY PLAYERS (2021) 217
3.18 ENDOSCOPY DEVICES COMPANY COMPARISON TABLE
BY REVENUE, PRODUCT, PRODUCT TYPE, AND APPLICATION 219
4 ENDOSCOPY DEVICES GLOBAL MARKET, BY APPLICATIONS 233
4.1 INTRODUCTION 233
4.2 ARTHROSCOPY 237
4.2.1 INTRODUCTION 237
4.2.2 KNEE ARTHROSCOPY 241
4.2.3 SHOULDER ARTHROSCOPY 244
4.2.4 WRIST ARTHROSCOPY 247
4.2.5 ANKLE ARTHROSCOPY 250
4.2.6 ELBOW ARTHROSCOPY 252
4.2.7 HIP ARTHROSCOPY 254
4.2.8 OTHER ARTHROSCOPY PROCEDURES 258
4.3 PULMONARY ENDOSCOPY 261
4.3.1 INTRODUCTION 261
4.3.2 BRONCHOSCOPY 265
4.3.3 THORACOSCOPY 269
4.3.4 MEDIASTINOSCOPY 272
4.4 ENT ENDOSCOPY 275
4.4.1 INTRODUCTION 275
4.4.2 NASAL ENDOSCOPY 280
4.4.3 LARYNGOSCOPY 284
4.4.4 OTOENDOSCOPY 288
4.4.5 TRANSNASAL ENDOSCOPY 290
4.5 GASTROINTESTINAL ENDOSCOPY 293
4.5.1 INTRODUCTION 293
4.5.2 ESOPHAGOGASTRODUODENOSCOPY 299
4.5.3 ENTEROSCOPY 303
4.5.4 COLONOSCOPY 308
4.5.5 SIGMOIDOSCOPY 313
4.5.6 PROCTOSCOPY 317
4.5.7 CHOLANGIOPANCREATOSCOPY 320
4.6 GYNECOLOGY/OBSTETRICS 324
4.6.1 INTRODUCTION 324
4.6.2 HYSTEROSCOPY 329
4.6.3 COLPOSCOPY 333
4.6.4 FALLOPOSCOPY 336
4.6.5 OTHER GYNECOLOGY/OBSTETRICS ENDOSCOPY APPLICATIONS 339
4.7 NEUROENDOSCOPY 342
4.7.1 INTRODUCTION 342
4.7.2 EPIDUROSCOPY OR SPINAL ENDOSCOPY 346
4.7.3 INTRAVENTRICULAR NEUROENDOSCOPY 349
4.7.4 TRANSCRANIAL NEUROENDOSCOPY 351
4.7.5 TRANSNASAL NEUROENDOSCOPY 354
4.8 UROLOGICAL ENDOSCOPY 356
4.8.1 INTRODUCTION 356
4.8.2 NEPHROSCOPY 361
4.8.3 CYSTOSCOPY 364
4.8.4 URETEROSCOPY 367
4.8.5 RESECTOSCOPY 370
4.9 LAPAROSCOPY 373
4.9.1 INTRODUCTION 373
4.9.2 LAPAROSCOPIC BARIATRIC SURGERY 378
4.9.3 LAPAROSCOPIC CHOLECYSTECTOMY 381
4.9.4 LAPAROSCPIC APPENDECTOMY 383
4.9.5 LAPAROSCOPIC HERNIA REPAIR 385
4.9.6 HAND ASSISTED LAPAROSCOPY 388
4.10 OTHER ENDOSCOPY APPLICATIONS 390
5 ENDOSCOPY DEVICES GLOBAL MARKET, BY PRODUCTS 395
5.1 INTRODUCTION 395
5.2 ENDOSCOPES 398
5.2.1 RIGID ENDOSCOPES 403
5.2.2 FLEXIBLE ENDOSCOPES 406
5.2.3 ROBOT-ASSISTED ENDOSCOPES, AND AI ENHANCED ENDOSCOPES 412
5.2.4 CAPSULE ENDOSCOPES 420
5.3 ENDOSCOPIC INSTRUMENTS 426
5.3.1 INTRODUCTION 426
5.3.2 ENDOSCOPIC CAMERAS 431
5.3.3 DIGITAL DOCUMENTATION SYSTEMS 435
5.3.4 LIGHT SOURCES 438
5.3.5 MONITORS, AND DISPLAY SYSTEMS 441
5.3.6 VIDEO CONVERTERS, AND PROCESSORS 445
5.3.7 FLUID MANAGEMENT SYSTEMS 447
5.3.8 OTHER ENDOSCOPIC INSTRUMENTS (INSUFFLATORS, ULTRASOUND PROBES, AND PROCESSORS) 450
5.4 ENDOSCOPIC ACCESSORIES 454
5.4.1 BIOPSY FORCEPS 459
5.4.2 GRASPERS, AND RETRACTORS 463
5.4.3 SNARES 467
5.4.4 TROCARS 471
5.4.5 SURGICAL DISSECTORS 474
5.4.6 OTHER ENDOSCOPIC ACCESSORIES 476
6 ENDOSCOPY DEVICES GLOBAL MARKET, BY END-USERS 483
6.1 INTRODUCTION 483
6.2 HOSPITALS 486
6.3 ENDOSCOPY AMBULATORY SURGERY CENTERS (EASC) OR AMBULATORY ENDOSCOPY CENTERS (AEC) 490
6.4 ENDOSCOPY DIAGNOSTIC CENTERS 493
6.5 OTHER END-USERS (OFFICE BASED ENDOSCOPY (OBE) SUITES, AND ACADEMIC, AND RESEARCH INSTITUTES) 495
7 GLOBAL ENDOSCOPY PROCEDURAL VOLUME 499
7.1 ENDOSCOPY - NUMBER OF PROCEDURES BY REGION 499
7.1.1 GLOBAL ARTHROSCOPY PROCEDURAL VOLUME 499
7.1.2 GLOBAL GASTROINTESTINAL ENDOSCOPY PROCEDURAL VOLUME 500
7.1.3 GLOBAL COLONOSCOPY PROCEDURAL VOLUME 501
7.1.4 GLOBAL UROLOGICAL ENDOSCOPY PROCEDURAL VOLUME 503
7.1.5 GLOBAL LAPAROSCOPY PROCEDURAL VOLUME 504
7.1.6 GLOBAL ENT ENDOSCOPY ROCEDURAL VOLUME 505
7.1.7 GLOBAL PULMONARY ENDOSCOPY PROCEDURAL VOLUME 506
7.1.8 GLOBAL NEUROENDOSCOPY PROCEDURAL VOLUME 508
8 REGIONAL MARKET ANALYSIS 511
8.1 INTRODUCTION 511
8.2 NORTH AMERICA 515
8.2.1 U.S. 553
8.2.2 REST OF NORTH AMERICA 563
8.3 EUROPE 575
8.3.1 GERMANY 614
8.3.2 FRANCE 622
8.3.3 UNITED KINGDOM 628
8.3.4 REST OF EUROPE 636
8.4 ASIA-PACIFIC 644
8.4.1 JAPAN 681
8.4.2 CHINA 690
8.4.3 INDIA 699
8.4.4 REST OF ASIA-PACIFIC (APAC) 708
8.5 REST OF THE WORLD (ROW) 717
8.5.1 BRAZIL 754
8.5.2 REST OF LATAM 762
8.5.3 MIDDLE EAST & OTHERS 769
9 COMPETITIVE LANDSCAPE 778
9.1 INTRODUCTION 778
9.2 PRODUCT APPROVAL 780
9.3 PRODUCT LAUNCH 783
9.4 ACQUISITIONS 785
9.5 COLLABORATIONS 787
9.6 OTHER DEVELOPMENTS 788
10 MAJOR PLAYER PROFILES 792
10.1 ARTHREX, INC. 792
10.1.1 OVERVIEW 792
10.1.2 FINANCIALS 792
10.1.3 PRODUCT PORTFOLIO 793
10.1.4 KEY DEVELOPMENTS 797
10.1.5 BUSINESS STRATEGY 798
10.1.6 SWOT ANALYSIS 799
10.2 B. BRAUN MELSUNGEN AG 800
10.2.1 OVERVIEW 800
10.2.2 FINANCIALS 801
10.2.3 PRODUCT PORTFOLIO 803
10.2.4 KEY DEVELOPMENTS 806
10.2.5 BUSINESS STRATEGY 806
10.2.6 SWOT ANALYSIS 808
10.3 BOSTON SCIENTIFIC CORPORATION 809
10.3.1 OVERVIEW 809
10.3.2 FINANCIALS 810
10.3.3 PRODUCT PORTFOLIO 813
10.3.4 KEY DEVELOPMENTS 815
10.3.5 BUSINESS STRATEGY 816
10.3.6 SWOT ANALYSIS 818
10.4 FUJIFILM HOLDINGS CORPORATION 819
10.4.1 OVERVIEW 819
10.4.2 FINANCIALS 820
10.4.3 PRODUCT PORTFOLIO 822
10.4.4 KEY DEVELOPMENTS 826
10.4.5 BUSINESS STRATEGY 828
10.4.6 SWOT ANALYSIS 830
10.5 HOYA CORPORATION (PENTAX MEDICAL) 831
10.5.1 OVERVIEW 831
10.5.2 FINANCIALS 832
10.5.3 PRODUCT PORTFOLIO 834
10.5.4 KEY DEVELOPMENTS 839
10.5.5 BUSINESS STRATEGY 839
10.5.6 SWOT ANALYSIS 841
10.6 JOHNSON & JOHNSON 842
10.6.1 OVERVIEW 842
10.6.2 FINANCIALS 843
10.6.3 PRODUCT PORTFOLIO 846
10.6.4 KEY DEVELOPMENTS 849
10.6.5 BUSINESS STRATEGY 850
10.6.6 SWOT ANALYSIS 851
10.7 KARL STORZ SE & CO. KG 852
10.7.1 OVERVIEW 852
10.7.2 FINANCIALS 852
10.7.3 PRODUCT PORTFOLIO 853
10.7.4 KEY DEVELOPMENTS 860
10.7.5 BUSINESS STRATEGY 861
10.7.6 SWOT ANALYSIS 862
10.8 MEDTRONIC, PLC. 863
10.8.1 OVERVIEW 863
10.8.2 FINANCIALS 864
10.8.3 PRODUCT PORTFOLIO 868
10.8.4 KEY DEVELOPMENTS 872
10.8.5 BUSINESS STRATEGY 872
10.8.6 SWOT ANALYSIS 873
10.9 OLYMPUS CORPORATION 874
10.9.1 OVERVIEW 874
10.9.2 FINANCIALS 875
10.9.3 PRODUCT PORTFOLIO 878
10.9.4 KEY DEVELOPMENTS 888
10.9.5 BUSINESS STRATEGY 891
10.9.6 SWOT ANALYSIS 893
10.10 STRYKER CORPORATION 894
10.10.1 OVERVIEW 894
10.10.2 FINANCIALS 895
10.10.3 PRODUCT PORTFOLIO 898
10.10.4 KEY DEVELOPMENTS 901
10.10.5 BUSINESS STRATEGY 901
10.10.6 SWOT ANALYSIS 903
听
听
*If Applicable.